Evaluation of sex hormone levels and some metabolic factors in men with coronary atherosclerosis

References

• Lerner DJ, Kannel WB. Patterns of coronary heart disease morbidity and mortality in the sexes: a 26- year follow-up of the Framingham population. Am Heart J 1986;111:383–90
   PubMed Web of Science ®Google Scholar
• Loaldi A, Annoni L, Apostolo A, et al. Coronary angiographic features in 2234 patients with clinical suspicion of coronary heart disease without modifiable risk factors. Jpn Heart J 1993;34:11–2
   PubMedGoogle Scholar
• Godsland IF, Wynn V, Crook D, Crook D, Miller NE. Sex, plasma lipoproteins, and athero- sclerosis: prevailing assumptions and outstanding questions. Am Heart J 1987;114:1467–503
   PubMed Web of Science ®Google Scholar
• Prevention of coronary heart disease in clinical practice. Recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention. Eur Heart J 1998;19:1434– 503
   Google Scholar
• Ng MK. Sex-related differences in the regulation of macrophage cholesterol metabolism. Curr Opin Lipidol 2001;12:505–10
   PubMed Web of Science ®Google Scholar
• Svec F, Porter J. Dehydroepiandrosterone in metabolic diseases. In Thijssen JH, Nieuwenhuyse H, eds. DHEA: A Comprehensive Review, 1st edn. London: Parthenon Publishing, 1999:105–26
   Google Scholar
• Khorram O. DHEA: a hormone with multiple effects. Curr Opin Obstet Gynecol 1996;8:351–4
   PubMed Web of Science ®Google Scholar
• Gooren LJ. Endocrine aspects of ageing in the male. Mol Cell Endocrinol 1998;145:153–9
   PubMed Web of Science ®Google Scholar
• Phillips GB, Pinkernell BH, Jing TY. The association between hypotestosteronemia and coronary artery disease in men. Atherioscler Thromb 1994;14:701–6
   PubMed Web of Science ®Google Scholar
• Libby P, Egan D, Skarlatos S. Roles of infectious agents in atherosclerosis and restenosis. An assess- ment of the evidence and need for future research. Circulation 1997;96:4095–103
   PubMed Web of Science ®Google Scholar
• Khaw KT, Barrett-Connor E. Endogenous sex hormones, high density lipoprotein cholesterol, and other lipoprotein fractions in men. Atherioscler Thromb 1991;11:489–94
   PubMedGoogle Scholar
• Greenfield JR, Samaras K, Chisholm DJ. Insulin resistance, intra-abdominal fat, cardiovascular risk factors, and androgens in healthy young women with type I diabetes mellitus. J Clin Endocrinol Metab 2002;87:1036–40
   PubMed Web of Science ®Google Scholar
• Fletcher GF, Balady GJ, Amsterdam EA, et al. Exercise standards for testing and training. A statement for healthcare professionals from the American Health Association. Circulation 2001; 104:1694–740
   PubMed Web of Science ®Google Scholar
• Mock MB, Ringqvist I, Fisher LD, Davis KB, Chaitman BR. Survival of medically treated patients in the Coronary Artery Surgery Study (CASS) registry. Circulation 1982;66:562–8
   PubMed Web of Science ®Google Scholar
• Katz A, Nambi SS, Mather K, et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 2000;85:2402–10
   PubMed Web of Science ®Google Scholar
• Alexandersen P, Haarbo J, Christiansen C. The relationship of natural androgens to coronary heart disease in males: a review. Atherosclerosis 1996; 125:1–13
   PubMed Web of Science ®Google Scholar
• LaCroix AZ, Yano K, Reed DM. Dehydroepian- drosterone sulfate, incidence of myocardial infarction and extent of atherosclerosis in men. Circulation 1992;86:1529–35
   PubMed Web of Science ®Google Scholar
• Barrett-Connor E, Khaw KT. Endogenous sex hormones and cardiovascular disease in men. A prospective population-based study. Circulation 1988;78:539–45
   PubMed Web of Science ®Google Scholar
• Yarnell JW, Beswick AD, Sweetnam PM, Riad-Fahmy D. Endogenous sex hormones and ischemic heart disease in men. The Caerphilly Prospective Study. Atherioscler Thromb 1993;13:517–20
   PubMedGoogle Scholar
• Gray A, Feldman HA, McKinlay JB, Longcope C. Age, disease, and changing sex hormone levels in middle-aged men: results of the Massachusetts Male Aging Study. J Clin Endocrinol Metab 1991; 73:1016–25
   PubMed Web of Science ®Google Scholar
• Schneider G, Kirschner M, Berkowitz R, Ertel M. Increased estrogen production in obese men. J Clin Endocrinol Metab 1979;48:633–8
   PubMed Web of Science ®Google Scholar
• Dai WS, Gutai JP, Kuller LH, Cauley J. Cigarette smoking and serum sex hormones in men. Am J Epidemiol 1988;128:796–805
   PubMed Web of Science ®Google Scholar
• Vermeulen A. Andropause. Maturitas 2000;34:5– 15
   Google Scholar
• English KM, Mandour O, Steeds RP, et al. Men with coronary artery disease have lower levels of androgens than men with normal coronary angiograms. Eur Heart J 2000;21:890–5
   PubMed Web of Science ®Google Scholar
• Goodpaster BH, Thaete FL, Simoneau JA, Kelley D. Subcutaneous abdominal fat and thigh muscle composition predict insulin sensitivity indepen- dently of visceral fat. Diabetes 1997;46:1579–85
   PubMed Web of Science ®Google Scholar
• Wajchenberg BL. Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocrine Rev 2000;21:697–738
   PubMed Web of Science ®Google Scholar
• Reaven GM. Role of insulin resistance in human disease. Diabetes 1988;37:1569–607
   Web of Science ®Google Scholar
• Castelli WP, Anderson K, Wilson PW, Levy D. Lipids and risk of coronary heart disease. The Framingham Study. Ann Epidemiol 1992;2:23–8
   PubMedGoogle Scholar
• Isidori AM, Caprio M, Strollo F, Moretti C, Frajese G. Leptin and androgens in male obesity: evidence for leptin contribution to reduced androgen levels. J Clin Endocrinol Metab 1999; 84:3673–80
   PubMed Web of Science ®Google Scholar
• Simon D, Preziosi P, Barrett-Connor E, Roger M, Saint-Paul M, Nahoul K. Association between plasma total testosterone and cardiovascular risk factors in healthy adult men: The Telecom Study. J Clin Endocrinol Metab 1997;82:682–5
   PubMed Web of Science ®Google Scholar